Brain+ A/S
CSE:BRAINP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Brain+ A/S
Other Liabilities
Brain+ A/S
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Brain+ A/S
CSE:BRAINP
|
Other Liabilities
kr16.7m
|
CAGR 3-Years
183%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
NNIT A/S
CSE:NNIT
|
Other Liabilities
kr28m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-5%
|
|
|
M
|
Monsenso A/S
CSE:MONSO
|
Other Liabilities
kr640k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Brain+ A/S
Glance View
Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.
See Also
What is Brain+ A/S's Other Liabilities?
Other Liabilities
16.7m
DKK
Based on the financial report for Dec 31, 2024, Brain+ A/S's Other Liabilities amounts to 16.7m DKK.
What is Brain+ A/S's Other Liabilities growth rate?
Other Liabilities CAGR 3Y
183%
Over the last year, the Other Liabilities growth was -13%. The average annual Other Liabilities growth rates for Brain+ A/S have been 183% over the past three years .
